| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
12,653,000 |
| Market
Cap: |
2.37(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.187 - $0.187 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kiora Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
10% Owner |
– – • |
2018-05-10 |
4 |
B |
$0.54 |
$12,982 |
D/D |
23,917 |
16,677,600 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-09 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,653,683 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-09 |
4 |
B |
$0.50 |
$51,571 |
D/D |
103,953 |
16,653,683 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,549,730 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-08 |
4 |
B |
$0.48 |
$17,718 |
D/D |
37,230 |
16,549,730 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-07 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,512,500 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-07 |
4 |
B |
$0.48 |
$6,888 |
D/D |
14,252 |
16,512,500 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-04 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,498,248 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-05-04 |
4 |
B |
$0.45 |
$38,866 |
D/D |
85,748 |
16,498,248 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-26 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,412,500 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-26 |
4 |
B |
$0.54 |
$43,016 |
D/D |
80,000 |
16,412,500 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,332,500 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-25 |
4 |
B |
$0.54 |
$46,250 |
D/D |
85,522 |
16,332,500 |
2.37 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-20 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,246,978 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-20 |
4 |
B |
$0.53 |
$261,701 |
D/D |
496,304 |
16,246,978 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-19 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
15,750,674 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-19 |
4 |
B |
$0.48 |
$599,299 |
D/D |
1,256,920 |
15,750,674 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-18 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
14,493,754 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-18 |
4 |
B |
$0.47 |
$370,158 |
D/D |
781,254 |
14,493,754 |
2.45 |
- |
|
| Romano Sarah |
Chief Financial Officer |
• – – |
2018-04-17 |
4 |
B |
$0.00 |
$0 |
D/D |
62,500 |
106,863 |
2.66 |
- |
|
| From Stephen |
President and CEO |
• • – |
2018-04-17 |
4 |
B |
$0.00 |
$0 |
D/D |
125,000 |
409,820 |
2.73 |
- |
|
| Garanzini Michael |
Chief Commercial Officer |
• – – |
2018-04-17 |
4 |
B |
$0.00 |
$0 |
D/D |
156,250 |
171,250 |
2.66 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-17 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
13,712,500 |
1.42 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-17 |
4 |
B |
$0.44 |
$837,670 |
D/D |
1,895,610 |
13,712,500 |
2.45 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-04-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
11,816,890 |
1.42 |
- |
|
289 Records found
|
|
Page 9 of 12 |
|
|
